More Than 80% Of Americans Report One Or More Symptoms Of Depression, And Many Have Turned To Substances To Cope With… May 18, 2021
Cybin Granted IRB Approval for Phase II Clinical Trials of its Sublingual Psilocybin Formulation for the Treatment of… May 18, 2021
Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip May 17, 2021
